Agreement - December 12, 2013
Biohit to distribute Dynex automated ELISA systems with Gastropanel
Finnish healthcare company Biohit Oyj and American company Dynex Technologies, Inc. have signed an agreement for the distribution of the two-microplate DS2®, four-microplate DSX® and 12-microplate Agility® automated ELISA (enzyme-linked immunosorbent assay) processing systems, for use with the Biohit Oyj GastroPanel. The agreement gives Biohit Oyj rights to distribute Dynex automated ELISA systems worldwide, effective […]
Agreement - November 29, 2013
Egalet enters collaboration with Shionogi
Denmark’s Egalet has entered into a collaboration and license agreement with Shionogi. The collaboration and agreement regards the development and potential commercialization of multiple oral abuse-deterrent hydrocodone opioid product candidates using Egalet’s proprietary technology. Egalet will receive a $10 million upfront payment from Shionogi. Furthermore, Shionogi has agreed to purchase up to approximately $15 million in common stock in a private placement to […]
Agreement - November 21, 2013
Biogaia signs exclusive agreement in Brazil
Biogaia has signed a long-term agreement with Aché for the exclusive rights to sell Biogaia’s probiotic drops and tablets in Brazil. According to Biogaia the products will be co-branded with expected launch in mid-2014. ”We are pleased to engage in an enduring collaboration with BioGaia, enabling the launch of relevant products in the Brazilian market. […]
Agreement - November 15, 2013
Orion licenses the levosimendan injection rights in the USA and Canada to Phyxius
Orion Corporation and Phyxius Pharma have entered into a licensing agreement for levosimendan injection. According to the agreement Phyxius Pharma will develop and commercialize levosimendan in the USA and Canada for a new cardiovascular indication, prevention of Low Cardiac Output Syndrome (LCOS) in cardiac surgery patients. LCOS is a common complication in patients undergoing cardiac […]
Agreement - October 31, 2013
Umecrine Cognition signs agreement with CleveXel Pharma
Umecrine Cognition, a Karolinska Development portfolio company, today announced that the company has entered into a partnering agreement with CleveXel Pharma regarding the development of its lead program in hepatic encephalopathy. According to the agreement, CleveXel Pharma will co-fund the development of Umecrine Cognition’s lead program in hepatic encephalopathy through investments in shares in the […]
Agreement - August 20, 2013
Sectra signs deal with British hospital
Spire Roding Hospital, part of the private healthcare group Spire, will be the first hospital in the Spire group to use Sectra’s online service to identify osteoporotic fractures at an early stage. “Osteoporosis can be an under-diagnosed disease and there is great need for simple, cost-effective methods of identifying patients in need of treatment. Being able […]
